» Articles » PMID: 21789096

Role of Inflammation in Bladder Function and Interstitial Cystitis

Overview
Journal Ther Adv Urol
Publisher Sage Publications
Date 2011 Jul 27
PMID 21789096
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Cystitis, or inflammation of the bladder, has a direct effect on bladder function. Interstitial cystitis is a syndrome characterized by urinary bladder pain and irritative symptoms of more than 6 months duration. It commonly occurs in young to middle-aged women with no known cause and in fact represents a diagnosis of exclusion. Many factors have been suggested, including chronic or subclinical infection, autoimmunity and genetic susceptibility, which could be responsible for initiating the inflammatory response. However, a central role of inflammation has been confirmed in the pathogenesis of interstitial cystitis. Patients with interstitial cystitis are usually managed with multimodal therapy to break the vicious cycle of chronic inflammation at every step. Patients who develop irreversible pathologies such as fibrosis are managed surgically, which is usually reserved for refractory cases.

Citing Articles

Inverse association between dietary flavonoid intake and nocturia in middle-aged and older adults from NHANES 2007-2010.

Cai Y, Liang Y, Hu X, Li L, Liu D, Chu S Sci Rep. 2025; 15(1):4423.

PMID: 39910320 PMC: 11799445. DOI: 10.1038/s41598-025-88681-2.


The association between depressive symptoms and lower urinary tract symptoms and impact among women: Investigating behavioural, cognitive and physiological pathways.

Brady S, Arguedas A, Huling J, Hellemann G, Jacobs Jr D, Lewis C Br J Health Psychol. 2025; 30(1):e12768.

PMID: 39838806 PMC: 11751663. DOI: 10.1111/bjhp.12768.


PACAP/PAC1 regulation in cystitis rats: induction of bladder inflammation cascade leading to bladder dysfunction.

Ke H, Zhu L, Zhang W, Wang H, Ding Z, Su D Front Immunol. 2024; 15:1413078.

PMID: 39669574 PMC: 11634801. DOI: 10.3389/fimmu.2024.1413078.


Therapeutic efficacy and short-term durability of trans-urethral amniotic bladder injections for the treatment of refractory COVID-associated cystitis.

Considine J, OHollaren K, Knapp J, Radoiu C, Liaw A, Dhar N Bladder (San Franc). 2024; 11(2):e21200010.

PMID: 39539472 PMC: 11555134. DOI: 10.14440/bladder.2024.0017.


Prolonged urinary retention in COVID-19 survivors: observational study.

Avilez N, Gon L, Achermann V, Riccetto C Rev Assoc Med Bras (1992). 2024; 70(11):e20240845.

PMID: 39536242 PMC: 11554313. DOI: 10.1590/1806-9282.20240845.


References
1.
Morales A, Emerson L, Nickel J, Lundie M . Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996; 156(1):45-8. View

2.
Sant G, Kempuraj D, Marchand J, Theoharides T . The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007; 69(4 Suppl):34-40. DOI: 10.1016/j.urology.2006.08.1109. View

3.
Spanos C, Letourneau R, Minogiannis P, Greenwood J, Siri P, Sant G . Carbachol-induced bladder mast cell activation: augmentation by estradiol and implications for interstitial cystitis. Urology. 1996; 48(5):809-16. DOI: 10.1016/S0090-4295(96)00239-7. View

4.
Koziol J, Clark D, Gittes R, Tan E . The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993; 149(3):465-9. DOI: 10.1016/s0022-5347(17)36120-7. View

5.
van Ophoven A, Hertle L . Long-term results of amitriptyline treatment for interstitial cystitis. J Urol. 2005; 174(5):1837-40. DOI: 10.1097/01.ju.0000176741.10094.e0. View